Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82cb42b3d2e5ccb3f3a772642d44d4f0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af4a44ab1d702e35fb8595031b271cde |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57426 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-50 |
filingDate |
2010-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ed010a2db3e1c80e3909301ce088e42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_771480024883fc95e6a3286fcfc0293f |
publicationDate |
2012-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2012128651-A1 |
titleOfInvention |
Acute lymphoblastic leukemia (all) biomarkers |
abstract |
The present invention concerns the use of biomarkers for acute lymphoblastic leukemia (ALL) to prognose or evaluate a patient with ALL who is Ph+. Methods and compositions are provided that concern these ALL biomarkers. In specific embodiments, methods for determining whether an ALL patient should be treated with standard chemotherapy are provided. |
priorityDate |
2009-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |